Showing results (141-150 of 989) with videos related to
Sort By:
Pageof 99
Therapeutic Advances in Respiratory Disease|April 4, 2023
Characteristics of initiators of budesonide/glycopyrrolate/formoterol for treatment of chronic obstructive pulmonary disease (COPD) in the United States: the AURA studyEdward C Portillo, Michael Pollack, Inyoung Lee, et al.Therapeutic Advances in Respiratory Disease|March 30, 2021
The impact of fluticasone furoate/vilanterol on healthcare resource utilisation in the Salford Lung Study in chronic obstructive pulmonary diseaseNawar Diar Bakerly, Dominy Browning, Isabelle Boucot, et al.Therapeutic Advances in Respiratory Disease|August 11, 2012
Diagnosis and management of pulmonary vasculitisZulma X Yunt, Stephen K Frankel, Kevin K BrownTherapeutic Advances in Respiratory Disease|September 13, 2012
Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, randomized, double-blind, controlled studyMaria Lucia Furnari, Lisa Termini, Gabriella Traverso, et al.Therapeutic Advances in Respiratory Disease|July 6, 2012
Triphala (PADMA) extract alleviates bronchial hyperreactivity in a mouse model through liver and spleen immune modulation and increased anti-oxidative effectsAmjad Horani, David Shoseyov, Isaac Ginsburg, et al.Therapeutic Advances in Respiratory Disease|April 12, 2015
Nintedanib in the treatment of idiopathic pulmonary fibrosisMariano E Mazzei, Luca Richeldi, Harold R CollardTherapeutic Advances in Respiratory Disease|June 7, 2014
Storage in ultra-low-temperature decreases the levels of IgM anticardiolipin antibody in serum samples from tuberculosis patientsAlexandra Ng, Cheyenne Weeks-Galindo, Amador GoodridgeTherapeutic Advances in Respiratory Disease|July 5, 2012
Chronic cough as a complication of treatment with statins: a case reportMatthew Psaila, Peter Fsadni, Stephen MontefortTherapeutic Advances in Respiratory Disease|July 1, 2020
Targeting the gut-lung microbiota axis by means of a high-fibre diet and probiotics may have anti-inflammatory effects in COVID-19 infectionLuana Conte, Domenico Maurizio ToraldoTherapeutic Advances in Respiratory Disease|October 13, 2012
Pulmonary arterial hypertension in pregnant womenZeenat SafdarPageof 99